Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

InspireMD (NSPR) Restructuring Costs (2024 - 2025)

InspireMD's Restructuring Costs history spans 3 years, with the latest figure at $1.3 million for Q4 2025.

  • For Q4 2025, Restructuring Costs rose 21.29% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $6.3 million, up 38.12%, while the annual FY2025 figure was $6.4 million, 37.72% up from the prior year.
  • Restructuring Costs reached $1.3 million in Q4 2025 per NSPR's latest filing, down from $1.8 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $1.8 million in Q3 2025 to a low of $1.1 million in Q4 2024.